The surge in demand for personalized medicine and the proliferation of orphan drug development are creating new avenues for biotechnology applications and are boosting the influx of emerging and innovative biotech companies. Further, technological innovation and supportive government funding and policies contribute to market growth.
Given the industry’s positive prospects, it could be ideal to keep an eye on quality biotech stocks G1 Therapeutics, Inc. (GTHX), Vanda Pharmaceuticals Inc. (VNDA), and Royalty Pharma PLC (RPRX) for potential gains.
